Lose Weight and Keep It Off

GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural hormone in your body. They work by slowing gastric emptying, reducing appetite, and improving insulin sensitivity. This leads to sustainable weight loss by addressing the biological drivers of hunger and metabolism.

This focus area is designed for adults (18+) with a BMI of 27 or higher, or those with weight-related health conditions. During intake, we screen for contraindications including pregnancy, history of pancreatitis, and certain thyroid conditions. A provider will review your case to ensure this is the right approach for you.

Lab work is essential for GLP-1 therapy because it helps us understand your metabolic health, rule out contraindications, and personalize your protocol. We check metabolic markers, thyroid function, kidney health, and other factors that influence both safety and effectiveness.

Most patients notice reduced appetite and early weight loss within 2-4 weeks. Significant results (10-15% body weight loss) typically occur over 12-16 weeks. Individual results vary based on starting weight, adherence, and metabolic factors identified in your labs.

Common side effects include nausea, which usually improves over time, and occasional constipation or diarrhea. Your provider will start you on a low dose and gradually increase to minimize side effects. Serious side effects are rare but monitored closely.

Yes, GLP-1 therapy is particularly effective for people who haven't achieved lasting results with diet and exercise alone. It addresses the biological mechanisms that make weight loss difficult and helps maintain results long-term.

After your initial active optimization phase, you can continue with month-to-month active optimization, transition into Yooth Continuity, or work with your provider on a tapering plan when appropriate. Many clients benefit from continued support to sustain their results.